EAM Response to the New UK Prime Minister 25th October 2022 Following the appointment of the new UK Prime Minister, the President of the Academy has issued a response outlining the critical role that scientific research and healthcare must play in the government’s agenda. The President emphasizes the importance of continued investment in science, innovation, and public health, urging the new administration to prioritize these areas to ensure the nation’s prosperity, resilience, and global leadership in medical science. The Role of Science in National Prosperity The Academy’s President highlights the indispensable role that scientific research and innovation play in driving economic growth, improving public health, and addressing the complex challenges of the modern world. The President calls on the new Prime Minister to reaffirm the government’s commitment to supporting research and development (R&D), particularly in the medical sciences, as a cornerstone of the UK’s future success. By investing in R&D, the UK can maintain its competitive edge on the global stage, develop cutting-edge technologies, and improve the quality of life for all citizens. The President stresses that the new government must prioritize policies that promote scientific excellence, ensure equitable access to healthcare, and support the education and training of the next generation of scientists and healthcare professionals. Strengthening the Healthcare System In the wake of the COVID-19 pandemic, the President underscores the need for robust and resilient healthcare systems that can adapt to emerging threats and provide high-quality care to all citizens. The new Prime Minister is urged to focus on strengthening the National Health Service (NHS), addressing workforce challenges, and ensuring that healthcare services are accessible and equitable across the UK. The Academy’s President also highlights the importance of integrating innovation into healthcare, including the adoption of new technologies and the implementation of data-driven approaches to improve patient outcomes. The President calls for continued collaboration between the government, healthcare providers, and the scientific community to ensure that the UK’s healthcare system remains world-class. Global Leadership in Medical Science As the UK navigates its post-Brexit future, the President emphasizes the importance of maintaining strong international collaborations in medical science and healthcare. The Academy calls on the new Prime Minister to foster partnerships with global research institutions, support international scientific initiatives, and ensure that the UK remains a leader in addressing global health challenges. The President also highlights the need for the UK to take a leadership role in addressing pressing issues such as climate change, antimicrobial resistance, and pandemic preparedness. By championing these causes on the international stage, the UK can contribute to a healthier, more sustainable world. Conclusion The Academy’s President welcomes the new UK Prime Minister and urges the government to prioritize science, healthcare, and global collaboration in its agenda. By investing in these areas, the UK can secure its future prosperity, enhance public health, and continue to lead in medical science on the world stage. The Academy remains committed to supporting the government in achieving these goals and advancing the nation’s scientific and healthcare capabilities.
